PET Imaging in the Management of Neuroendocrine Tumors, An Issue of PET Clinics, 1st Edition

Authors :
Stefano Fanti & Cristina Nanni & Richard Baum
Nuclear Medicine has greatly contributed to the diagnosis and treament of neuroendocrine neoplasms. This issue of PET Clinics will focus not only on the diagnosis and treatment of neuroendocrine tumors, but also theranostics. Topics include SPECT and ...view more
Nuclear Medicine has greatly contributed to the diagnosis and treament of neuroendocrine neoplasms. This issue of PET Clinics will focus not only on the diagnosis and treatment of neuroendocrine tumors, but also theranostics. Topics include SPECT and other PET tracers, F-DOPA, Ga-DOTA-peptides, Yttrium- and Lutetium-based therapy, and the role of FDG PET. It also covers key information of theranostics.
Add to Cart
Nuclear Medicine has greatly contributed to the diagnosis and treament of neuroendocrine neoplasms. This issue of PET Clinics will focus not only on the diagnosis and treatment of neuroendocrine tumors, but also theranostics. Topics include SPECT and other PET tracers, F-DOPA, Ga-DOTA-peptides, Yttrium- and Lutetium-based therapy, and the role of FDG PET. It also covers key information of theranostics.

Author Information
By Stefano Fanti, Intitute of Nuclear Medicine, University of Bologna, Italy; Cristina Nanni, MD, Intitute of Nuclear Medicine, University of Bologna, Italy and Richard P. Baum, MD, Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Germany